Clinical Efficacy of JAK Inhibitors in Patients with Vexas Syndrome: A Multicenter Retrospective Study
Maël Heiblig(Université Claude Bernard Lyon 1), Pierre Sujobert(Université Claude Bernard Lyon 1), Matthew J. Koster(Mayo Clinic in Arizona), Pierre Fenaux(Saint Louis University Hospital), Lionel Galicier(Hôpital de la Timone), Thomas Barba(Lyon 1 Université), Henrique Coelho(Centro Hospitalar de Vila Nova de Gaia), Tanaz A. Kermani(University of Ottawa), Guillaume Vial(Hôpital Saint-André), Adrien Bigot(Université de Tours), Fiorenza Barraco(Hôpital Lyon Sud), Kenneth J. Warrington(Mayo Clinic), David B. Beck(Center for Human Genetics), Yvan Jamilloux(Hospices Civils de Lyon), Boris Bienvenu(Hôpital Saint Joseph), Pierre Hirsch(Inserm), Gaëlle Fossard(Hospices Civils de Lyon), Bhavisha A. Patel(MACOM (United States)), Marcela A. Ferrada(University of Maryland, Baltimore), G. Le Guenno(Hôpital Saint-André), A. Mékinian(Sorbonne Université), Peter C. Grayson(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Anne Blandine Boutin(Centre Hospitalier René-Dubos), Mathieu Gerfaud‐Valentin(Hospices Civils de Lyon)
Cited by 12
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k